Morgan Stanley stays Overweight on Johnson & Johnson (JNJ) following 'expected positive' Ico approval
Tweet Send to a Friend
Morgan Stanley analyst Terrance Flynn reiterated an Overweight rating and $262.00 price target on Johnson & Johnson (NYSE: JNJ)The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
